Changes in Ventilation Inhomogeneity and Respiratory Function Following Elective Caesarean Section Under Regional Anaesthesia (VIRCA)

October 30, 2016 updated by: Walid HABRE

Changes in Ventilation Inhomogeneity and Respiratory Function Following Elective Caesarean Section Under Regional Anaesthesia: a Prospective Observational Study

Pregnancy is associated with physiological changes affecting the cardiorespiratory system as a consequence of an increase in both cardiac output and intra-abdominal pressure. The aim of this prospective observational study is to examine the perioperative changes in ventilation inhomogeneity and respiratory function measured by the non-invasive nitrogen multiple breath washout and forced oscillation techniques.

Study Overview

Status

Withdrawn

Conditions

Detailed Description

Pregnancy is associated with physiological changes affecting the cardiorespiratory system as a consequence of an increase in both cardiac output and intra-abdominal pressure. These alterations lead to a ventilation/perfusion mismatch which is potentiated by a decrease in functional residual capacity (FRC). These effects explain why pregnant women are more prone to the occurrence of hypoxemia, particularly in the third trimester of their pregnancy. The importance of the ventilation inhomogeneity can be estimated from the lung clearance index (LCI) measured by the non-invasive nitrogen multiple breath washout (N2 MBW) technique. Moreover the loss in lung volume is associated with reduction in respiratory system compliance, which can also be assessed non-invasively by the forced oscillation technique (FOT).

To our knowledge, there is no existing data on LCI or FRC using the aforementioned techniques in pregnant women. Furthermore, existing data on respiratory function in pregnant women is largely restricted to spirometric and body plethysmographic measurements taken primarily in the 1970s-1980s. As such, the important roles of lung ventilation inhomogeneity as well as the potential changes following birth after caesarean section have yet to be completely characterised.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Geneva, Switzerland, 1206
        • University Hospitals of Geneva

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Pregnant women scheduled for elective caesarean section in gestational weeks 37-40

Description

Inclusion Criteria:

  • Written informed consent
  • Pregnant woman in the third trimester (37-40 weeks gestational age)
  • Scheduled for elective caesarean section under regional (spinal or combined spinal-epidural) anaesthesia

Exclusion Criteria:

  • Pregnant women outside 37-40 weeks gestational age
  • Non-singleton pregnancy
  • Previous history of ≥2 caesarean sections
  • History or clinical signs of cardiopulmonary disease in the last 12 months (chronic hypertension, gestational hypertension, preeclampsia, asthma, acute or chronic bronchitis, others)
  • Positive current smoking status
  • Pre-pregnant body mass index (BMI) >30 kg/m2 (based on booking records)
  • Respiratory infection <2 weeks prior to surgery
  • Inability to perform the respiratory function tests

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perioperative changes in ventilation inhomogeneity (LCI) following delivery by caesarean section
Time Frame: 1-3 days prior to caesarean section until 5 days postoperative
Nitrogen multiple breath washout technique
1-3 days prior to caesarean section until 5 days postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alterations in FRC throughout the postpartum period
Time Frame: 1-3 days prior to caesarean section until 5 days postoperative
Nitrogen multiple breath washout technique
1-3 days prior to caesarean section until 5 days postoperative
Changes in respiratory mechanics: respiratory system compliance (Crs)
Time Frame: 1-3 days prior to caesarean section until 5 days postoperatively
Forced oscillation technique
1-3 days prior to caesarean section until 5 days postoperatively
Changes in respiratory mechanics: airway resistance (Raw)
Time Frame: 1-3 days prior to caesarean section until 5 days postoperatively
Forced oscillation technique
1-3 days prior to caesarean section until 5 days postoperatively
Perioperative respiratory complications
Time Frame: During caesarean section until 5 days postoperatively
Apnoea/bradypnoea, oxygen desaturation <90%/hypoxemia, hypoventilation/atelectasis, pulmonary embolism, incoercible cough
During caesarean section until 5 days postoperatively
Perioperative respiratory interventions
Time Frame: During caesarean section until 5 days postoperatively
Intubation, oxygen therapy, bronchodilator, adrenaline, continuous positive airways pressure (CPAP), respiratory physiotherapy
During caesarean section until 5 days postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Walid Habre, MD, PhD, University of Geneva

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Anticipated)

October 1, 2016

Study Completion (Anticipated)

October 1, 2016

Study Registration Dates

First Submitted

March 1, 2016

First Submitted That Met QC Criteria

March 15, 2016

First Posted (Estimate)

March 21, 2016

Study Record Updates

Last Update Posted (Estimate)

November 1, 2016

Last Update Submitted That Met QC Criteria

October 30, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Physiologic measures of lung function

Subscribe